Evaluation of Safety, Tolerability, Pharmacokinetics, and Antiretroviral Activity of Ulonivirine (MK-8507) in Human Immunodeficiency Virus (HIV-1)-Infected Participants (MK-8507-003)
Clinical trial NCT02174159 · COMPLETED
Trial details
- NCT number
- NCT02174159
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-09-15
- Primary completion
- 2015-07-16
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.